EUVIMEDEUVIMED entdecken
Crossref

Exploring the Association of Small Dense Low-Density Lipoprotein Cholesterol and Ischemia-Modified Albumin in Hyperlipidemic Patients

Dr. Juan Carlos Mendoza, Dr. Laura Sofía Ramírez

Frontiers in Medical and Clinical Sciences · 2025

DOI: 10.64917/fmcs-003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Medical and Clinical Sciences, 2025. Verfasst von Dr. Juan Carlos Mendoza und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Small dense low-density lipoprotein cholesterol (sdLDL-C) is recognized as a highly atherogenic lipoprotein subfraction implicated in cardiovascular risk. Ischemia-modified albumin (IMA) serves as a biomarker of oxidative stress and ischemic conditions. Both markers are important in understanding the pathophysiology of hyperlipidemia-related cardiovascular diseases.

Objective

This study investigates the relationship between sdLDL-C levels and IMA concentrations in patients with hyperlipidemia to elucidate potential synergistic roles in cardiovascular risk stratification.

Methods

A cross-sectional analysis was conducted on hyperlipidemic patients attending a tertiary care center. Serum sdLDL-C and IMA levels were measured and correlated with lipid profiles and clinical parameters. Statistical analyses evaluated the strength and significance of associations.

Results

Elevated sdLDL-C levels showed a significant positive correlation with increased IMA concentrations, indicating heightened oxidative stress in hyperlipidemic patients. This association suggests that combined measurement of sdLDL-C and IMA could improve early detection of vascular ischemia and risk assessment.

Conclusion

The findings support a close link between atherogenic lipoprotein subfractions and ischemia-related oxidative modifications in hyperlipidemia. Integrating sdLDL-C and IMA assessments may enhance cardiovascular risk prediction and guide therapeutic interventions.

Zitieren

APA

Mendoza, D. J. C., & Ramírez, D. L. S. (2025). Exploring the Association of Small Dense Low-Density Lipoprotein Cholesterol and Ischemia-Modified Albumin in Hyperlipidemic Patients. Frontiers in Medical and Clinical Sciences. https://doi.org/10.64917/fmcs-003

Vancouver

Mendoza DJC, Ramírez DLS. Exploring the Association of Small Dense Low-Density Lipoprotein Cholesterol and Ischemia-Modified Albumin in Hyperlipidemic Patients. Frontiers in Medical and Clinical Sciences. 2025. doi:10.64917/fmcs-003

BibTeX
@article{Mendoza2025,
  author = {Mendoza, Dr. Juan Carlos and Ramírez, Dr. Laura Sofía},
  title = {Exploring the Association of Small Dense Low-Density Lipoprotein Cholesterol and Ischemia-Modified Albumin in Hyperlipidemic Patients},
  journal = {Frontiers in Medical and Clinical Sciences},
  year = {2025},
  doi = {10.64917/fmcs-003}
}
Kostenlos starten →